See more : Allied Minds plc (ALM.L) Income Statement Analysis – Financial Results
Complete financial analysis of CM Life Sciences II Inc. (CMIIU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CM Life Sciences II Inc., a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Jindal Saw Limited (JINDALSAW.NS) Income Statement Analysis – Financial Results
- Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRES.BA) Income Statement Analysis – Financial Results
- Howmet Aerospace Inc. (HWM) Income Statement Analysis – Financial Results
- BHP Group Limited (BIL.DE) Income Statement Analysis – Financial Results
- Linc AB (LINC.ST) Income Statement Analysis – Financial Results
CM Life Sciences II Inc. (CMIIU)
About CM Life Sciences II Inc.
CM Life Sciences II Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
Unable to fetch income statement for: CMIIU
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies
BOULDER, Colo. & SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (Nasdaq: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to...
ARK Investment Leans Into Biotech and Telecom Holdings
Catherine Wood (Trades, Portfolio)'s ARK Investment has revealed additions to three biotechnology and telecommunications holdings according to GuruFocus' Real-Time Picks, a Premium feature.
SomaLogic Customizable Protein Panels With Industry-Leading 7,000-Plex Assay Now Available
NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)--CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein panel products are now available to pharma, biotechnology and academic research customers seeking...
SomaLogic Latest to Take SPAC Route to Public Markets
SomaLogic is joining the growing number of companies going public via special purpose acquisition companies. The Boulder, Colorado-based health care company plans to merge with CM Life Sciences II Inc. (NASDAQ:CMIIU), whose lead entity is Casdin Capital LLC, a life-sciences...
CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $240 Million Initial Public Offering
NEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (the “Company”) announced today that it priced its initial public offering of 24,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the...
Source: https://incomestatements.info
Category: Stock Reports